opzelura - ruxolitinib cream
(Ruxolitinib)Incyte Corporation
Usage: Opzelura treats mild to moderate atopic dermatitis in adults and children 2+ years not adequately controlled by topical therapies, and nonsegmental vitiligo in adults and adolescents 12+ years. Not recommended with biologics, other JAK inhibitors, or potent immunosuppressants.